Anorectal melanoma: histopathological and immunohistochemical features and treatment

Cruz, Geraldo Magela Gomes da; Andrade Filho, José de Souza; Patrus, Gil; Leite, Sinara Mônica de Oliveira; Silva, Ilson Geraldo da; Teixeira, Ricardo Guimarães; Braga, Áurea Cassia Gualberto; Ferreira, Renata Magali Ribeiro Silluzio.
J. coloproctol. (Rio J., Impr.) ; 34(2): 95-103, Apr-Jun/2014. tab, ilus
Artigo em Inglês | LILACS | ID: lil-714699

Documentos relacionados

  1. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer.
  2. Study identifies signs and symptoms of colorectal cancer risk at younger ages.
  3. Thromboelastography (TEG) parameters as potential predictors of malignancy and tumor progression in colorectal cancer.
  4. Conflicting Guidelines: A Systematic Review on the Proper Interval for Colorectal Cancer Treatment.
  5. [Expert consensus on the early diagnosis and treatment of colorectal cancer in China (2023 edition)].
  6. Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies.
  7. The Current Landscape of Research Advocacy and Education for Patients with Colorectal Cancer.
  8. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
  9. Anti-PD-1 therapy for advanced colorectal cancer based on intestinal microecology.
  10. Antigen-presenting CAFs.